A Study to Evaluate the Effectiveness and Safety of CAEL-101 in Patients With AL Amyloidosis

Condition:   AL Amyloidosis Interventions:   Drug: CAEL-101;   Other: Placebo;   Drug: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) Sponsors:   Caelum Biosciences;   IQVIA Biotech Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials